Exiqon A/S today announces that it has granted a license to Applied Biosystems (NYSE:ABI), an Applera Corporation business, to use Exiqon's proprietary Locked Nucleic Acids (LNA) in siRNA
Exiqon A/S today announces that it has granted a license to Applied Biosystems (NYSE:ABI), an Applera Corporation business, to use Exiqon's proprietary Locked Nucleic Acids (LNA) in siRNA